|
1.
|
Assimacopoulos A, Johnston B, Clabots C, Johnson JR. Post-Prostate Biopsy Infection with Escherichia coli ST131 Leading to Epididymo-Orchitis and Meningitis Caused by Gram-Negative Bacilli. J Clin Microbiol. 2012 Dec; 50(12):4157-9.
|
|
|
|
|
2.
|
Olesen B, Scheutz F, Andersen RL, Menard M, Boisen N, Johnston B, Hansen DS, Krogfelt KA, Nataro JP, Johnson JR. Enteroaggregative Escherichia coli O78:H10, the Cause of an Outbreak of Urinary Tract Infection. J Clin Microbiol. 2012 Nov; 50(11):3703-11.
|
|
|
|
|
3.
|
Spurbeck RR, Dinh PC, Walk ST, Stapleton AE, Hooton TM, Nolan LK, Kim KS, Johnson JR, Mobley HL. Escherichia coli Isolates That Carry vat, fyuA, chuA, and yfcV Efficiently Colonize the Urinary Tract. Infect Immun. 2012 Dec; 80(12):4115-22.
|
|
|
|
|
4.
|
Johnson JR, Johnston B, Kuskowski MA. In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms. Antimicrob Agents Chemother. 2012 Sep; 56(9):4969-72.
|
|
|
|
|
5.
|
Johnson JR. Fostering high-value, cost-conscious care. Ann Intern Med. 2012 Jun 19; 156(12):902-3.
|
|
|
|
|
6.
|
Manges AR, Johnson JR. Food-Borne Origins of Escherichia coli Causing Extraintestinal Infections. Clin Infect Dis. 2012 Sep; 55(5):712-9.
|
|
|
|
|
7.
|
Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A, Clabots CR, Johnston B, Cobbold RN. Prominence of an O75 Clonal Group (Clonal Complex 14) among Non-ST131 Fluoroquinolone-Resistant Escherichia coli Causing Extraintestinal Infections in Humans and Dogs in Australia. Antimicrob Agents Chemother. 2012 Jul; 56(7):3898-904.
|
|
|
|
|
8.
|
Rocha JL, Tuon FF, Johnson JR. Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. Braz J Infect Dis. 2012 Apr; 16(2):115-21.
|
|
|
|
|
9.
|
Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis. 2012 Apr; 18(4):598-607.
|
|
|
|
|
10.
|
Johnson TJ, Wannemuehler Y, Kariyawasam S, Johnson JR, Logue CM, Nolan LK. Prevalence of Avian-Pathogenic Escherichia coli Strain O1 Genomic Islands among Extraintestinal and Commensal E. coli Isolates. J Bacteriol. 2012 Jun; 194(11):2846-53.
|
|
|
|
|
11.
|
Leuck AM, Wright D, Ellingson L, Kraemer L, Kuskowski MA, Johnson JR. Complications of foley catheters-is infection the greatest risk? J Urol. 2012 May; 187(5):1662-6.
|
|
|
|
|
12.
|
Platell JL, Cobbold RN, Johnson JR, Clabots CR, Trott DJ. Fluoroquinolone-resistant extraintestinal Escherichia coli clinical isolates representing the O15:K52:H1 clonal group from humans and dogs in Australia. Comp Immunol Microbiol Infect Dis. 2012 Jul; 35(4):319-24.
|
|
|
|
|
13.
|
Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-ß-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother. 2012 May; 56(5):2364-70.
|
|
|
|
|
14.
|
Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. Virulence of Escherichia coli Clinical Isolates in a Murine Sepsis Model in Relation to Sequence Type ST131 Status, Fluoroquinolone Resistance, and Virulence Genotype. Infect Immun. 2012 Apr; 80(4):1554-62.
|
|
|
|
|
15.
|
Woods KL, Johnson JR, Padkowsky S, Mariano N, Colon-Urban R, Hassanein M, Wehbeh W, Johnston BD, Clabots C, Zahid S, Urban C. Community-Associated Escherichia coli Harboring CTX-M ß-Lactamases from Urine Cultures from Pediatric Patients. Antimicrob Agents Chemother. 2012 Apr; 56(4):2209-10.
|
|
|
|
|
16.
|
Tiruvury H, Johnson JR, Mariano N, Grenner L, Colon-Urban R, Erritouni M, Wehbeh W, Segal-Maurer S, Rahal JJ, Johnston B, Urban C. Identification of CTX-M ß-lactamases among Escherichia coli from the community in New York City. Diagn Microbiol Infect Dis. 2012 Mar; 72(3):248-52.
|
|
|
|
|
17.
|
Weissman SJ, Johnson JR, Tchesnokova V, Billig M, Dykhuizen D, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Scholes D, Chattopadhyay S, Sokurenko E. High-Resolution Two-Locus Clonal Typing of Extraintestinal Pathogenic Escherichia coli. Appl Environ Microbiol. 2012 Mar; 78(5):1353-60.
|
|
|
|
|
18.
|
Kudinha T, Kong F, Johnson JR, Andrew SD, Anderson P, Gilbert GL. Multiplex PCR-Based Reverse Line Blot Assay for Simultaneous Detection of 22 Virulence Genes in Uropathogenic Escherichia coli. Appl Environ Microbiol. 2012 Feb; 78(4):1198-202.
|
|
|
|
|
19.
|
Sokurenko E, Johnson JR. Clonal identity of Escherichia coli as a predictive factor for recurrent cystitis. Virulence. 2011 Nov 1; 2(6):495-7.
|
|
|
|
|
20.
|
Johnson JR, Menard ME, Lauderdale TL, Kosmidis C, Gordon D, Collignon P, Maslow JN, Tambic Andrasevic A, Kuskowski MA. Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998-2007. Emerg Infect Dis. 2011 Nov; 17(11):2001-9.
|
|
|
|
|
21.
|
Reeves PR, Liu B, Zhou Z, Li D, Guo D, Ren Y, Clabots C, Lan R, Johnson JR, Wang L. Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS One. 2011; 6(10):e26907.
|
|
|
|
|
22.
|
Johnson TJ, Logue CM, Johnson JR, Kuskowski MA, Sherwood JS, Barnes HJ, Debroy C, Wannemuehler YM, Obata-Yasuoka M, Spanjaard L, Nolan LK. Associations Between Multidrug Resistance, Plasmid Content, and Virulence Potential Among Extraintestinal Pathogenic and Commensal Escherichia coli from Humans and Poultry. Foodborne Pathog Dis. 2012 Jan; 9(1):37-46.
|
|
|
|
|
23.
|
Drekonja DM, Amundson WH, Decarolis DD, Kuskowski MA, Lederle FA, Johnson JR. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med. 2011 Nov; 124(11):1081.e1-7.
|
|
|
|
|
24.
|
Spurbeck RR, Stapleton AE, Johnson JR, Walk ST, Hooton TM, Mobley HL. Fimbrial Profiles Predict Virulence of Uropathogenic Escherichia coli Strains: Contribution of Ygi and Yad Fimbriae. Infect Immun. 2011 Dec; 79(12):4753-63.
|
|
|
|
|
25.
|
Colgan R, Williams M, Johnson JR. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician. 2011 Sep 1; 84(5):519-26.
|
|
|
|
|
26.
|
Owens RC, Johnson JR, Stogsdill P, Yarmus L, Lolans K, Quinn J. Community Transmission in the United States of a CTX-M-15-Producing Sequence Type ST131 Escherichia coli Strain Resulting in Death. J Clin Microbiol. 2011 Sep; 49(9):3406-8.
|
|
|
|
|
27.
|
Johnson JR. Foodborne illness acquired in the United States. Emerg Infect Dis. 2011 Jul; 17(7):1338-9.
|
|
|
|
|
28.
|
Johnson JR. Rifampin and Methicillin-Resistant Staphylococcus aureus Bone and Joint Infections. Clin Infect Dis. 2011 Jul; 53(1):98-9.
|
|
|
|
|
29.
|
Platell JL, Cobbold RN, Johnson JR, Heisig A, Heisig P, Clabots C, Kuskowski MA, Trott DJ. Commonality among Fluoroquinolone-Resistant Sequence Type ST131 Extraintestinal Escherichia coli Isolates from Humans and Companion Animals in Australia. Antimicrob Agents Chemother. 2011 Aug; 55(8):3782-7.
|
|
|
|
|
30.
|
Knoll BM, Wright D, Ellingson L, Kraemer L, Patire R, Kuskowski MA, Johnson JR. Reduction of inappropriate urinary catheter use at a veterans affairs hospital through a multifaceted quality improvement project. Clin Infect Dis. 2011 Jun; 52(11):1283-90.
|
|
|
|
|
31.
|
Johnson JR. Extended-Spectrum B-Lactamase-producing Escherichia coli in Neonatal Care Unit. Emerg Infect Dis. 2011 Jun; 17(6):153-1154.
|
|
|
|
|
32.
|
Platell JL, Johnson JR, Cobbold RN, Trott DJ. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol. 2011 Nov 21; 153(1-2):99-108.
|
|
|
|
|
33.
|
Vigil PD, Stapleton AE, Johnson JR, Hooton TM, Hodges AP, He Y, Mobley HL. Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli Predicts Successful Colonization of the Urinary Tract. MBio. 2011; 2(3).
|
|
|
|
|
34.
|
Shamliyan TA, Johnson JR, Macdonald R, Shaukat A, Yuan JM, Kane RL, Wilt TJ. Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection. J Gen Intern Med. 2011 Mar; 26(3):326-39.
|
|
|
|
|
35.
|
Rudick CN, Berry RE, Johnson JR, Johnston B, Klumpp DJ, Schaeffer AJ, Thumbikat P. Uropathogenic Escherichia coli Induces Chronic Pelvic Pain. Infect Immun. 2011 Feb; 79(2):628-35.
|
|
|
|
|
36.
|
Drekonja DM, Kuskowski MA, Johnson JR. Foley catheter practices and knowledge among Minnesota physicians. Am J Infect Control. 2010 Nov; 38(9):694-700.
|
|
|
|
|
37.
|
Johnson JR, Johnston BD, Kuskowski MA, Pitout J. In Vitro Activity of Available Antimicrobial Coated Foley Catheters Against Escherichia coli, Including Strains Resistant to Extended Spectrum Cephalosporins. J Urol. 2010 Dec; 184(6):2572-7.
|
|
|
|
|
38.
|
Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug-Resistant E. coli Infections in the United States. Clin Infect Dis. 2010 Aug 1; 51(3):286-94.
|
|
|
|
|
39.
|
Platell JL, Cobbold RN, Johnson JR, Trott DJ. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother. 2010 Sep; 65(9):1936-8.
|
|
|
|
|
40.
|
Bert F, Johnson JR, Ouattara B, Leflon-Guibout V, Johnston B, Marcon E, Valla D, Moreau R, Nicolas-Chanoine MH. Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol. 2010 Aug; 48(8):2709-14.
|
|
|
|
|
41.
|
Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr Infect Dis J. 2010 May; 29(5):473-5.
|
|
|
|
|
42.
|
Coelho A, González-López JJ, Miró E, Alonso-Tarrés C, Mirelis B, Larrosa MN, Bartolomé RM, Andreu A, Navarro F, Johnson JR, Prats G. Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. Int J Antimicrob Agents. 2010 Jul; 36(1):73-8.
|
|
|
|
|
43.
|
Urban C, Mariano N, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, Colon-Urban R, Johnston B, Johnson JR, Rahal JJ. Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn Microbiol Infect Dis. 2010 Apr; 66(4):402-6.
|
|
|
|
|
44.
|
Drekonja DM, Okoye NC, Kuskowski MA, Johnson JR. Appropriateness of urinary tract infection diagnosis and treatment duration. Arch Intern Med. 2010 Mar 8; 170(5):489-90.
|
|
|
|
|
45.
|
Johnson JR. Comparing costs and quality of care at retail clinics with those of other medical settings. Ann Intern Med. 2010 Feb 16; 152(4):266-7; author reply 267.
|
|
|
|
|
46.
|
Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 1; 50(3):374-80.
|
|
|
|
|
47.
|
Johnson JR, Johnston B, Clabots C, Kuskowski MA, Pendyala S, Debroy C, Nowicki B, Rice J. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother. 2010 Jan; 54(1):546-50.
|
|
|
|
|
48.
|
Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, Johnson JR. Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis. J Clin Microbiol. 2009 Nov; 47(11):3780-2.
|
|
|
|
|
49.
|
Drekonja DM, Kuskowski MA, Johnson JR. Internet survey of Foley catheter practices and knowledge among Minnesota nurses. Am J Infect Control. 2010 Feb; 38(1):31-7.
|
|
|
|
|
50.
|
Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol. 2009 Nov; 47(11):3721-5.
|
|
|
|
|
51.
|
Coelho A, Mirelis B, Alonso-Tarrés C, Nieves Larrosa M, Miró E, Clivillé Abad R, Bartolomé RM, Castañer M, Prats G, Johnson JR, Navarro F, González-López JJ. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. J Antimicrob Chemother. 2009 Oct; 64(4):862-4.
|
|
|
|
|
52.
|
Johnson JR, McCabe JS, White DG, Johnston B, Kuskowski MA, McDermott P. Molecular Analysis of Escherichia coli from retail meats (2002-2004) from the United States National Antimicrobial Resistance Monitoring System. Clin Infect Dis. 2009 Jul 15; 49(2):195-201.
|
|
|
|
|
53.
|
Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother. 2009 Jul; 53(7):2733-9.
|
|
|
|
|
54.
|
Lescat M, Calteau A, Hoede C, Barbe V, Touchon M, Rocha E, Tenaillon O, Médigue C, Johnson JR, Denamur E. A module located at a chromosomal integration hot spot is responsible for the multidrug resistance of a reference strain from Escherichia coli clonal group A. Antimicrob Agents Chemother. 2009 Jun; 53(6):2283-8.
|
|
|
|
|
55.
|
Hannah EL, Johnson JR, Angulo F, Haddadin B, Williamson J, Samore MH. Molecular analysis of antimicrobial-susceptible and -resistant Escherichia coli from retail meats and human stool and clinical specimens in a rural community setting. Foodborne Pathog Dis. 2009 Apr; 6(3):285-95.
|
|
|
|
|
56.
|
Olesen B, Scheutz F, Menard M, Skov MN, Kolmos HJ, Kuskowski MA, Johnson JR. Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J Clin Microbiol. 2009 Jun; 47(6):1857-62.
|
|
|
|
|
57.
|
Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, Bidet P, Bingen E, Bonacorsi S, Bouchier C, Bouvet O, Calteau A, Chiapello H, Clermont O, Cruveiller S, Danchin A, Diard M, Dossat C, Karoui ME, Frapy E, Garry L, Ghigo JM, Gilles AM, Johnson J, Le Bouguénec C, Lescat M, Mangenot S, Martinez-Jéhanne V, Matic I, Nassif X, Oztas S, Petit MA, Pichon C, Rouy Z, Ruf CS, Schneider D, Tourret J, Vacherie B, Vallenet D, Médigue C, Rocha EP, Denamur E. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet. 2009 Jan; 5(1):e1000344.
|
|
|
|
|
58.
|
Shamliyan TA, MacDonald R, Shaukat A, Taylor BC, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL, Wilt TJ. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med. 2009 Jan 20; 150(2):111-24.
|
|
|
|
|
59.
|
Moreno E, Johnson JR, Pérez T, Prats G, Kuskowski MA, Andreu A. Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect. 2009 Feb; 11(2):274-80.
|
|
|
|
|
60.
|
Drekonja DM, Traynor LM, DeCarolis DD, Crossley KB, Johnson JR. Treatment of non-life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective review. Diagn Microbiol Infect Dis. 2009 Feb; 63(2):201-7.
|
|
|
|
|
61.
|
Sidjabat HE, Chin JJ, Chapman T, Wu K, Ulett GC, Ong CY, Schembri MA, Johnson JR, Trott DJ. Colonisation dynamics and virulence of two clonal groups of multidrug-resistant Escherichia coli isolated from dogs. Microbes Infect. 2009 Jan; 11(1):100-7.
|
|
|
|
|
62.
|
Johnson JR, Johnston B, Kuskowski MA, Nougayrede JP, Oswald E. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J Clin Microbiol. 2008 Dec; 46(12):3906-11.
|
|
|
|
|
63.
|
Johnson JR, Clabots C, Kuskowski MA. Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members. J Clin Microbiol. 2008 Dec; 46(12):4078-82.
|
|
|
|
|
64.
|
Johnson JR, Kuskowski MA, Owens K, Clabots C, Singer RS. Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection. Vet Microbiol. 2009 Apr 14; 136(1-2):108-14.
|
|
|
|
|
65.
|
Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL. Management of chronic hepatitis B. Evid Rep Technol Assess (Full Rep). 2008 Oct; (174):1-671.
|
|
|
|
|
66.
|
Johnson TJ, Wannemuehler Y, Johnson SJ, Stell AL, Doetkott C, Johnson JR, Kim KS, Spanjaard L, Nolan LK. Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol. 2008 Nov; 74(22):7043-50.
|
|
|
|
|
67.
|
Drekonja DM, Kuskowski MA, Wilt TJ, Johnson JR. Antimicrobial urinary catheters: a systematic review. Expert Rev Med Devices. 2008 Jul; 5(4):495-506.
|
|
|
|
|
68.
|
Hill J, Beriwal S, Chandra I, Paul VK, Kapil A, Singh T, Wadowsky RM, Singh V, Goyal A, Jahnukainen T, Johnson JR, Tarr PI, Vats A. Loop-mediated isothermal amplification assay for rapid detection of common strains of Escherichia coli. J Clin Microbiol. 2008 Aug; 46(8):2800-4.
|
|
|
|
|
69.
|
Drekonja DM, Johnson JR. Urinary tract infections. Prim Care. 2008 Jun; 35(2):345-67, vii.
|
|
|
|
|
70.
|
Moreno E, Andreu A, Pigrau C, Kuskowski MA, Johnson JR, Prats G. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol. 2008 Aug; 46(8):2529-34.
|
|
|
|
|
71.
|
Leevy WM, Lambert TN, Johnson JR, Morris J, Smith BD. Quantum dot probes for bacteria distinguish Escherichia coli mutants and permit in vivo imaging. Chem Commun (Camb). 2008 May 28; (20):2331-3.
|
|
|
|
|
72.
|
Sannes MR, Belongia EA, Kieke B, Smith K, Kieke A, Vandermause M, Bender J, Clabots C, Winokur P, Johnson JR. Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin. J Infect Dis. 2008 Feb 1; 197(3):430-4.
|
|
|
|
|
73.
|
Johnson JR, Owens K, Gajewski A, Clabots C. Escherichia coli colonization patterns among human household members and pets, with attention to acute urinary tract infection. J Infect Dis. 2008 Jan 15; 197(2):218-24.
|
|
|
|
|
74.
|
Groom H, Dieperink E, Nelson DB, Garrard J, Johnson JR, Ewing SL, Stockley H, Durfee J, Jonk Y, Willenbring ML, Ho SB. Outcomes of a Hepatitis C screening program at a large urban VA medical center. J Clin Gastroenterol. 2008 Jan; 42(1):97-106.
|
|
|
|
|
75.
|
Colgan R, Johnson JR, Kuskowski M, Gupta K. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother. 2008 Mar; 52(3):846-51.
|
|
|
|
|
76.
|
Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008 Feb; 61(2):273-81.
|
|
|
|
|
77.
|
Johnson JR, Johnston B, Murray A, Kuskowski MA, Maslow JN, Johnson C. Bacterial characteristics as predictors of posttherapy recurrent bacteriuria among children with acute uncomplicated cystitis caused by Escherichia coli. Pediatr Infect Dis J. 2007 Dec; 26(12):1151-3.
|
|
|
|
|
78.
|
Johnson JR, Johnston B, Clabots CR, Kuskowski MA, Roberts E, DebRoy C. Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J Clin Microbiol. 2008 Feb; 46(2):417-22.
|
|
|
|
|
79.
|
Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, Schaeffer AJ. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun. 2007 Nov; 75(11):5353-60.
|
|
|
|
|
80.
|
Shaikh N, Holt NJ, Johnson JR, Tarr PI. Fim operon variation in the emergence of Enterohemorrhagic Escherichia coli: an evolutionary and functional analysis. FEMS Microbiol Lett. 2007 Aug; 273(1):58-63.
|
|
|
|
|
81.
|
Johnson JR, Sannes MR, Croy C, Johnston B, Clabots C, Kuskowski MA, Bender J, Smith KE, Winokur PL, Belongia EA. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis. 2007 Jun; 13(6):838-46.
|
|
|
|
|
82.
|
Boczek LA, Rice EW, Johnston B, Johnson JR. Occurrence of antibiotic-resistant uropathogenic Escherichia coli clonal group A in wastewater effluents. Appl Environ Microbiol. 2007 Jul; 73(13):4180-4.
|
|
|
|
|
83.
|
Wallace-Gadsden F, Johnson JR, Wain J, Okeke IN. Enteroaggregative Escherichia coli related to uropathogenic clonal group A. Emerg Infect Dis. 2007 May; 13(5):757-60.
|
|
|
|
|
84.
|
Johnson JR. Escherichia coil cluster evaluation. Emerg Infect Dis. 2007 Mar; 13(3):520.
|
|
|
|
|
85.
|
Johnson TJ, Kariyawasam S, Wannemuehler Y, Mangiamele P, Johnson SJ, Doetkott C, Skyberg JA, Lynne AM, Johnson JR, Nolan LK. The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol. 2007 Apr; 189(8):3228-36.
|
|
|
|
|
86.
|
Russo TA, Beanan JM, Olson R, Genagon SA, MacDonald U, Cope JJ, Davidson BA, Johnston B, Johnson JR. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine. 2007 May 10; 25(19):3859-70.
|
|
|
|
|
87.
|
Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis. 2006 Nov 15; 43(10):e101-8.
|
|
|
|
|
88.
|
Clermont O, Johnson JR, Menard M, Denamur E. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis. 2007 Feb; 57(2):129-36.
|
|
|
|
|
89.
|
Knott A, Dieperink E, Willenbring ML, Heit S, Durfee JM, Wingert M, Johnson JR, Thuras P, Ho SB. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol. 2006 Oct; 101(10):2254-62.
|
|
|
|
|
90.
|
Qin X, Razia Y, Johnson JR, Stapp JR, Boster DR, Tsosie T, Smith DL, Braden CR, Gay K, Angulo FJ, Tarr PI. Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children. Antimicrob Agents Chemother. 2006 Oct; 50(10):3325-9.
|
|
|
|
|
91.
|
Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, Denamur E. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis. 2006 Oct 15; 194(8):1141-50.
|
|
|
|
|
92.
|
Skyberg JA, Johnson TJ, Johnson JR, Clabots C, Logue CM, Nolan LK. Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun. 2006 Nov; 74(11):6287-92.
|
|
|
|
|
93.
|
Lymberopoulos MH, Houle S, Daigle F, Léveillé S, Brée A, Moulin-Schouleur M, Johnson JR, Dozois CM. Characterization of Stg fimbriae from an avian pathogenic Escherichia coli O78:K80 strain and assessment of their contribution to colonization of the chicken respiratory tract. J Bacteriol. 2006 Sep; 188(18):6449-59.
|
|
|
|
|
94.
|
Johnson JR. Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection. Ann Intern Med. 2006 Aug 1; 145(3):232; author reply 232-3.
|
|
|
|
|
95.
|
Léveillé S, Caza M, Johnson JR, Clabots C, Sabri M, Dozois CM. Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor. Infect Immun. 2006 Jun; 74(6):3427-36.
|
|
|
|
|
96.
|
Johnson JR, Kuskowski MA, Menard M, Gajewski A, Xercavins M, Garau J. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis. 2006 Jul 1; 194(1):71-8.
|
|
|
|
|
97.
|
Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB. Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect. 2006 Jun; 8(7):1702-13.
|
|
|
|
|
98.
|
Weissman SJ, Chattopadhyay S, Aprikian P, Obata-Yasuoka M, Yarova-Yarovaya Y, Stapleton A, Ba-Thein W, Dykhuizen D, Johnson JR, Sokurenko EV. Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol. 2006 Feb; 59(3):975-88.
|
|
|
|
|
99.
|
Russo TA, Johnson JR. Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development. Expert Rev Vaccines. 2006 Feb; 5(1):45-54.
|
|
|
|
|
100.
|
Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med. 2006 Jan 17; 144(2):116-26.
|
|
|
|
|
101.
|
Moreno E, Prats G, Sabaté M, Pérez T, Johnson JR, Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother. 2006 Feb; 57(2):204-11.
|
|
|
|
|
102.
|
Johnson JR, Clabots C, Rosen H. Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect Immun. 2006 Jan; 74(1):461-8.
|
|
|
|
|
103.
|
Johnson JR, Owens K, Gajewski A, Kuskowski MA. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol. 2005 Dec; 43(12):6064-72.
|
|
|
|
|
104.
|
Johnson JR. Virulence factors in Escherichia coli. J Clin Microbiol. 2005 Dec; 43(12):6221; author reply 6221-2.
|
|
|
|
|
105.
|
Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2005 Nov; 49(11):4667-70.
|
|
|
|
|
106.
|
Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother. 2005 Nov; 49(11):4739-44.
|
|
|
|
|
107.
|
Hannah EL, Angulo FJ, Johnson JR, Haddadin B, Williamson J, Samore MH. Drug-resistant Escherichia coli, Rural Idaho. Emerg Infect Dis. 2005 Oct; 11(10):1614-7.
|
|
|
|
|
108.
|
Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol. 2005 Oct; 295(6-7):383-404.
|
|
|
|
|
109.
|
Kuntaman K, Lestari ES, Severin JA, Kershof IM, Mertaniasih NM, Purwanta M, Hadi U, Johnson JR, van Belkum A, Verbrugh HA. Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis. 2005 Sep; 11(9):1363-9.
|
|
|
|
|
110.
|
Johnson JR. Escherichia coli clonal group A. Clin Infect Dis. 2005 Aug 15; 41(4):568; author reply 568-70.
|
|
|
|
|
111.
|
Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O'Bryan TT, Sandberg T. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol. 2005 Aug; 43(8):3895-900.
|
|
|
|
|
112.
|
Horcajada JP, Soto S, Gajewski A, Smithson A, Jiménez de Anta MT, Mensa J, Vila J, Johnson JR. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol. 2005 Jun; 43(6):2962-4.
|
|
|
|
|
113.
|
Johnson JR, Kuskowski MA, Smith K, O'Bryan TT, Tatini S. Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods. J Infect Dis. 2005 Apr 1; 191(7):1040-9.
|
|
|
|
|
114.
|
Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O'Bryan TT, Sandberg T. Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection. Clin Infect Dis. 2005 Mar 15; 40(6):813-22.
|
|
|
|
|
115.
|
Johnson JR, Jelacic S, Schoening LM, Clabots C, Shaikh N, Mobley HL, Tarr PI. The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun. 2005 Feb; 73(2):965-71.
|
|
|
|
|
116.
|
Johnson JR. Reinfection versus relapse in urinary tract infection. Clin Infect Dis. 2005 Feb 1; 40(3):495; author reply 495-6.
|
|
|
|
|
117.
|
Johnson JR, Murray AC, Kuskowski MA, Schubert S, Prère MF, Picard B, Colodner R, Raz R. Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis. 2005 Jan; 11(1):141-5.
|
|
|
|
|
118.
|
Johnson JR, Kuskowski MA, O'bryan TT, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother. 2005 Jan; 49(1):26-31.
|
|
|
|
|
119.
|
Johnson JR, Delavari P, O'Bryan TT, Smith KE, Tatini S. Contamination of retail foods, particularly turkey, from community markets (Minnesota, 1999-2000) with antimicrobial-resistant and extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis. 2005; 2(1):38-49.
|
|
|
|
|
120.
|
Ramchandani M, Manges AR, DebRoy C, Smith SP, Johnson JR, Riley LW. Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis. 2005 Jan 15; 40(2):251-7.
|
|
|
|
|
121.
|
Johnson JR, Kuskowski MA, Gajewski A, Soto S, Horcajada JP, Jimenez de Anta MT, Vila J. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis. 2005 Jan 1; 191(1):46-50.
|
|
|
|
|
122.
|
Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis. 2004 Dec 15; 190(12):2121-8.
|
|
|
|
|
123.
|
Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J Infect Dis. 2004 Nov 15; 190(10):1739-44.
|
|
|
|
|
124.
|
Sannes MR, Kuskowski MA, Johnson JR. Geographical distribution of antimicrobial resistance among Escherichia coli causing acute uncomplicated pyelonephritis in the United States. FEMS Immunol Med Microbiol. 2004 Oct 1; 42(2):213-8.
|
|
|
|
|
125.
|
Johnson JR. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004 Sep 15; 39(6):873; author reply 873-4.
|
|
|
|
|
126.
|
Manges AR, Johnson JR, Riley LW. Intestinal population dynamics of UTI-causing Escherichia coli within heterosexual couples. Curr Issues Intest Microbiol. 2004 Sep; 5(2):49-57.
|
|
|
|
|
127.
|
Maslow JN, Lautenbach E, Glaze T, Bilker W, Johnson JR. Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance. Antimicrob Agents Chemother. 2004 Sep; 48(9):3618-20.
|
|
|
|
|
128.
|
Johnson JR. Assessment of patients with chest pain. Ann Intern Med. 2004 Aug 17; 141(4):325-6; author reply 326.
|
|
|
|
|
129.
|
Johnson JR, Owens K, Sabate M, Prats G. Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR. J Clin Microbiol. 2004 Aug; 42(8):3841-3.
|
|
|
|
|
130.
|
Sannes MR, Kuskowski MA, Johnson JR. Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans. J Am Vet Med Assoc. 2004 Aug 1; 225(3):368-73.
|
|
|
|
|
131.
|
Johnson JR, Owens K, Manges AR, Riley LW. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J Clin Microbiol. 2004 Jun; 42(6):2618-22.
|
|
|
|
|
132.
|
Murray AC, Kuskowski MA, Johnson JR. Virulence factors predict Escherichia coli colonization patterns among human and animal household members. Ann Intern Med. 2004 May 18; 140(10):848-9.
|
|
|
|
|
133.
|
Johnson JR, O'Bryan TT. Detection of the Escherichia coli group 2 polysaccharide capsule synthesis Gene kpsM by a rapid and specific PCR-based assay. J Clin Microbiol. 2004 Apr; 42(4):1773-6.
|
|
|
|
|
134.
|
Johnson JR, Clabots C, Hirt H, Waters C, Dunny G. Enterococcal aggregation substance and binding substance are not major contributors to urinary tract colonization by Enterococcus faecalis in a mouse model of ascending unobstructed urinary tract infection. Infect Immun. 2004 Apr; 72(4):2445-8.
|
|
|
|
|
135.
|
Sokurenko EV, Feldgarden M, Trintchina E, Weissman SJ, Avagyan S, Chattopadhyay S, Johnson JR, Dykhuizen DE. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol. 2004 Jul; 21(7):1373-83.
|
|
|
|
|
136.
|
Johnson JR. Reduction of nephrotoxicity associated with amphotericin B deoxycholate. Clin Infect Dis. 2004 Jan 15; 38(2):303; author reply 306-7.
|
|
|
|
|
137.
|
Johnson JR, Gajewski A, Lesse AJ, Russo TA. Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol. 2003 Dec; 41(12):5798-802.
|
|
|
|
|
138.
|
Johnson JR. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003 Nov 18; 139(10):863; author reply 864.
|
|
|
|
|
139.
|
Prats G, Mirelis B, Miró E, Navarro F, Llovet T, Johnson JR, Camps N, Domínguez A, Salleras L. Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerg Infect Dis. 2003 Oct; 9(10):1273-80.
|
|
|
|
|
140.
|
Johnson JR. Multiple blood cultures for diagnosing bacteremia. Clin Infect Dis. 2003 Sep 1; 37(5):738.
|
|
|
|
|
141.
|
Johnson JR, Lockman HA, Owens K, Jelacic S, Tarr PI. High-frequency secondary mutations after suicide-driven allelic exchange mutagenesis in extraintestinal pathogenic Escherichia coli. J Bacteriol. 2003 Sep; 185(17):5301-5.
|
|
|
|
|
142.
|
Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis. 2003 Sep 1; 188(5):759-68.
|
|
|
|
|
143.
|
Johnson JR. Hospital-onset infections: a patient safety issue. Ann Intern Med. 2003 Aug 5; 139(3):233-4.
|
|
|
|
|
144.
|
Johnson JR. Appropriateness of fluoroquinolones for therapy of urinary tract infection. Arch Intern Med. 2003 Jul 14; 163(13):1616-7; author reply 1618.
|
|
|
|
|
145.
|
Johnson JR, Murray AC, Gajewski A, Sullivan M, Snippes P, Kuskowski MA, Smith KE. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother. 2003 Jul; 47(7):2161-8.
|
|
|
|
|
146.
|
Johnson JR. Dedicated catheter lumens for parenteral nutrition. Clin Infect Dis. 2003 Jun 15; 36(12):1625-6; author reply 1626.
|
|
|
|
|
147.
|
Johnson JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am. 2003 Jun; 17(2):261-78, viii.
|
|
|
|
|
148.
|
Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003 Apr; 5(5):449-56.
|
|
|
|
|
149.
|
Johnson JR. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2003 Jan 15; 36(2):236-7.
|
|
|
|
|
150.
|
Williams DN, Sannes MR, Eckhoff AA, Peterson PK, Johnson JR, Sannes MR, San Román M, Mora N, Moya J. Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int J Antimicrob Agents. 2003 Jan; 21(1):79-81.
|
|
|
|
|
151.
|
Johnson JR, Kaster N, Kuskowski MA, Ling GV. Identification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E. coli isolates from dogs with urinary tract infection. J Clin Microbiol. 2003 Jan; 41(1):337-45.
|
|
|
|
|
152.
|
Johnson JR. Practical aspects of choosing antibiotic therapy for patients with a reported antibiotic allergy. Clin Infect Dis. 2002 Dec 15; 35(12):1573-4; author reply 1574.
|
|
|
|
|
153.
|
Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Barnard TJ, Johnson JR. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun. 2002 Dec; 70(12):7156-60.
|
|
|
|
|
154.
|
Johnson JR. Escherichia coli pathogenicity island-like domains. Infect Immun. 2002 Dec; 70(12):7185; author reply 7185-6.
|
|
|
|
|
155.
|
Johnson JR, van der Schee C, Kuskowski MA, Goessens W, van Belkum A. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis. 2002 Dec 15; 186(12):1852-6.
|
|
|
|
|
156.
|
Johnson JR. Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis. 2002 Sep 1; 35(5):632; author reply 632-3.
|
|
|
|
|
157.
|
Johnson JR, Delavari P. Concurrent fecal colonization with extraintestinal pathogenic Escherichia coli in a homosexual man with recurrent urinary tract infection and in his male sex partner. Clin Infect Dis. 2002 Sep 15; 35(6):E65-8.
|
|
|
|
|
158.
|
Johnson JR, Russo TA. Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections. J Infect Dis. 2002 Sep 15; 186(6):859-64.
|
|
|
|
|
159.
|
Spruance SL, Nett R, Marbury T, Wolff R, Johnson J, Spaulding T. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother. 2002 Jul; 46(7):2238-43.
|
|
|
|
|
160.
|
Johnson JR, Manges AR, O'Bryan TT, Riley LW. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet. 2002 Jun 29; 359(9325):2249-51.
|
|
|
|
|
161.
|
Johnson JR, Stell AL, O'Bryan TT, Kuskowski M, Nowicki B, Johnson C, Maslow JN, Kaul A, Kavle J, Prats G. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Clin Microbiol. 2002 Jun; 40(6):1913-23.
|
|
|
|
|
162.
|
Johnson JR, Jerome C, Boster DR, Stapleton AE, Tarr PI. Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin. J Clin Microbiol. 2002 Jun; 40(6):2247-8.
|
|
|
|
|
163.
|
Johnson JR. Principles of judicious antibiotic use: acute rhinosinusitis. Ann Intern Med. 2002 May 7; 136(9):708-9.
|
|
|
|
|
164.
|
Johnson JR. Principles of judicious antibiotic use: nonspecific upper respiratory tract infections. Ann Intern Med. 2002 May 7; 136(9):709.
|
|
|
|
|
165.
|
Gordon DM, Bauer S, Johnson JR. The genetic structure of Escherichia coli populations in primary and secondary habitats. Microbiology. 2002 May; 148(Pt 5):1513-22.
|
|
|
|
|
166.
|
Johnson JR, Kuskowski MA, O'Bryan TT, Maslow JN. Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J Infect Dis. 2002 May 15; 185(10):1439-47.
|
|
|
|
|
167.
|
Starcic M, Johnson JR, Stell AL, van der Goot J, Hendriks HG, van Vorstenbosch C, van Dijk L, Gaastra W. Haemolytic Escherichia coli isolated from dogs with diarrhea have characteristics of both uropathogenic and necrotoxigenic strains. Vet Microbiol. 2002 Apr 2; 85(4):361-77.
|
|
|
|
|
168.
|
Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E coli". J Lab Clin Med. 2002 Mar; 139(3):155-62.
|
|
|
|
|
169.
|
Johnson JR, Oswald E, O'Bryan TT, Kuskowski MA, Spanjaard L. Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis. 2002 Mar 15; 185(6):774-84.
|
|
|
|
|
170.
|
Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J, Johnson J, Hacker JK, Shieh WJ, Hendry RM, Nikkari S, Ladd-Wilson S, Hadler J, Rainbow J, Tappero JW, Woods CW, Conn L, Reagan S, Zaki S, Perkins BA. Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis. 2002 Feb; 8(2):145-53.
|
|
|
|
|
171.
|
Johnson JR. Prevention of antibiotic resistance in hospitals. Ann Intern Med. 2002 Jan 15; 136(2):173 author reply 173.
|
|
|
|
